Correlation of PET-CT Studies With Serum Protein Analysis

Carcinomas (Including Squamous Cell and Adenocarcinoma) Clinical Trial

Official title:

Correlation of PET-CT Studies With Serum Protein Analysis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00547742
• Other study ID #: VAR0011
• Secondary ID: 96184VAR0011
• Status: Completed
• Phase: N/A
• First received: October 19, 2007
• Last updated: July 16, 2010
• Start date: July 2005
• Est. completion date: June 2009

Study information

• Verified date: July 2010
• Source: Stanford University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

To correlate serum proteomics patterns with PET/CT findings to improve cancer diagnosis, staging, prognosis, and therapy monitoring.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1500
• Est. completion date: June 2009
• Est. primary completion date: March 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:1. Patients must have a PET/CT study performed at the time of blood collection.

2. Patients must understand and voluntarily sign an Informed Consent form after the contents have been fully explained to them.

Exclusion Criteria:1. Patients who are not eligible for a PET/CT study.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Adenocarcinoma
• Carcinomas (Including Squamous Cell and Adenocarcinoma)

Intervention

Procedure:
• PET/CT Scan

• phlebotomy

Locations

Country	Name	City	State
United States	Stanford University School of Medicine	Stanford	California

Sponsors (1)

Lead Sponsor	Collaborator
Stanford University

Country where clinical trial is conducted

United States,